| 1992 |
RAB5B was identified as a 215-amino-acid small GTPase that binds GTP and GDP, displays low intrinsic GTP hydrolysis activity (~0.005/min), and localizes to the plasma membrane by subcellular fractionation and indirect immunofluorescence. |
GST fusion protein purification, GTP/GDP binding assay, GTP hydrolysis assay, indirect immunofluorescence, subcellular fractionation |
The Journal of Clinical Investigation |
Medium |
1541686
|
| 1999 |
EEA1 (early endosomal autoantigen) directly interacts with RAB5B in a GTP-dependent manner via both its C-terminal and N-terminal domains, and EEA1 colocalizes with RAB5B on early endosomes. A pig brain cytosol GAP activity preferentially stimulates RAB5B GTPase activity over RAB5A. |
Yeast two-hybrid screen, biochemical binding confirmation, confocal immunofluorescence, GTPase activity assay |
European Journal of Biochemistry |
High |
10491193
|
| 1999 |
The three RAB5 isoforms (RAB5A, RAB5B, RAB5C) are differentially phosphorylated in vitro: RAB5A is efficiently phosphorylated by ERK1 but not ERK2, while cdc2 kinase preferentially phosphorylates Ser-123 of RAB5B. |
In vitro kinase assay with recombinant proteins and purified kinases (ERK1, ERK2, cdc2) |
FEBS Letters |
Medium |
10403367
|
| 2004 |
RAB5B is required for DHPG-mediated neuroprotection against NMDA toxicity in organotypic hippocampal cultures; antisense oligonucleotide knockdown of RAB5B suppressed DHPG-induced protection, and this protection was abolished by disrupting endocytosis via osmotic shock/K+ depletion, placing RAB5B in a pathway facilitating NMDA receptor endocytosis. |
Antisense oligonucleotide knockdown in organotypic hippocampal cultures, cell viability assay, pharmacological inhibition of endocytosis |
Brain Research |
Medium |
15518642
|
| 2015 |
LRRK2 kinase phosphorylates RAB5B at Thr6 in vitro and in cells expressing LRRK2 G2019S. Phosphomimetic T6D mutation enhances RAB5B GTPase activity and produces phenotypes consistent with inactive RAB5B (longer neurite length, reduced EGFR degradation), suggesting LRRK2 acts as a GAP-like regulator of RAB5B signaling. |
In vitro kinase assay with recombinant proteins, mass spectrometry, western blot with phospho-specific approach, neurite outgrowth assay, EGFR degradation assay, GTPase activity assay |
Journal of Biochemistry |
High |
25605758
|
| 2019 |
RAB5B knockdown increases HBV DNA production >30-fold by increasing LHBs mRNA transcription (via HNF4α upregulation) and is required for transport of large hepatitis B surface protein (LHBs) from the ER to multivesicular bodies (MVB); depletion causes LHBs accumulation in the ER. |
siRNA knockdown in HepG2.2.15 cells, northern blotting, immunofluorescence microscopy, siRNA screen of 62 Rab proteins |
Journal of Virology |
Medium |
31118260
|
| 2018 |
RAB5B is a direct target of miR-130a-3p; overexpression of miR-130a-3p downregulates RAB5B protein and knockdown of RAB5B inhibits proliferation, migration, and invasion of breast cancer stem cell-like cells. |
miRNA overexpression/knockdown, RAB5B siRNA knockdown, proliferation/migration/invasion assays |
Biochemical and Biophysical Research Communications |
Medium |
29746865
|
| 2022 |
A dominant negative RAB5B variant (p.Asp136His) causes defective early endosome (EE) fusion and endocytosis, leading to failure to process proSP-B and proSP-C into mature surfactant proteins SP-B and SP-C in alveolar type II cells. RAB5B and EEA1 colocalize with proSP-B and proSP-C in normal lung, establishing RAB5B and early endosomes as required for the surfactant protein trafficking/processing pathway. |
Knock-in of variant into C. elegans ortholog (genetic epistasis), endocytosis assays, early endosome fusion assay, immunostaining of patient lung biopsy, colocalization microscopy |
Proceedings of the National Academy of Sciences of the United States of America |
High |
35121658
|
| 2023 |
RAB5B is upregulated by tranexamic acid (TXA) in keratinocytes and promotes clustering of endocytic melanocores; RAB5B silencing reduces melanocore clustering, and melanocores colocalize with RAB5B and LAMP1. |
Transcriptome sequencing, RAB5B siRNA silencing, transmission electron microscopy, colocalization microscopy |
Experimental Dermatology |
Low |
36779692
|
| 2024 |
RAB5B interacts with CD109 in KRAS-mutant pancreatic cancer cells; this interaction bypasses canonical endosomal trafficking by anchoring RAB5B to lipid rafts of multivesicular bodies, facilitating packaging of circPNIT into CD109+ extracellular vesicles. |
Co-immunoprecipitation, lipid raft fractionation, extracellular vesicle isolation and analysis, in vitro and in vivo functional assays |
Advanced Science |
Low |
39488792
|
| 2025 |
Under nutrient stress (serum withdrawal), the LC3 lipidation complex (ATG5–ATG12–ATG16L1) is recruited to synapses via RAB5B-positive endosomes in a dynein-dependent manner, coupling nutrient sensing to localized synaptic autophagy. Live imaging shows enhanced RAB5B–ATG16L1 co-trafficking and increased ATG5 mobility upon serum withdrawal. |
Live imaging, co-trafficking analysis, dynein inhibition, autophagy assays, synaptic proteomics |
bioRxiv (preprint)preprint |
Low |
bio_10.1101_2025.11.25.690410
|